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Background: Nonalcoholic fatty liver disease (NAFLD) is a risk for hepatocellular carcinoma (HCC), but the
association between a high-fructose diet and HCC is not fully understood. In this study, we investigated whether a
high-fructose diet affects hepatocarcinogenesis induced by administration of diethylnitrosamine (DEN).
Methods: Seven-week-old male Sprague–Dawley rats were fed standard chow (controls), a high-fat diet (54% fat),
or a high-fructose diet (66% fructose) for 8 weeks. All rats were given DEN at 50 μg/L in drinking water during the
same period. Precancerous hepatocytes were detected by immunostaining of the placental form of glutathione-S-
transferase (GST-P). The number of GST-P-positive hepatocytes was assessed in liver specimens.
Results: Serum levels of total cholesterol were similar among the three groups, but serum triglyceride, fasting
blood glucose, and insulin levels were higher in the high-fructose group compared to the high-fat group. In
contrast, hepatic steatosis was more severe in the high-fat group compared with the high-fructose and control
groups, but the incidence of GST-P-positive specimens was significantly higher in the high-fructose group
compared to the other two groups. The average number of GST-P-positive hepatocytes in GST-P positive specimens
in the high-fructose group was also higher than those in the other two groups. This high prevalence of GST-P-
positive hepatocytes was accompanied by higher levels of 8-hydroxydeoxyguanosine in serum and liver tissue.
Conclusions: These results indicate that dietary fructose, rather than dietary fat, increases the incidence of
precancerous hepatocytes induced by administration of DEN via insulin resistance and oxidative stress in rat. Thus,
excessive fructose intake may be a potential risk factor for hepatocarcinogenesis.
Keywords: Diethylnitrosamine, Fructose, Hepatocarcinogenesis, Nonalcoholic steatohepatitis, Placental form of
glutathione-S-transferaseBackground
Fatty liver is roughly divided into alcoholic and nonalco-
holic fatty liver diseases. Nonalcoholic fatty liver disease
(NAFLD) includes nonalcoholic fatty liver without hepa-
tocellular injury and fibrosis, and nonalcoholic steatohe-
patitis (NASH) accompanied by liver inflammation and
hepatocyte injury with a risk of hepatic cirrhosis and* Correspondence: hirouto@m2.kufm.kagoshima-u.ac.jp
1Digestive and Lifestyle Diseases, Department of Human and Environmental
Sciences, Kagoshima University Graduate School of Medical and Dental
Sciences, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 890-8544, Japan
Full list of author information is available at the end of the article
© 2013 Kumamoto et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumhepatocellular carcinoma (HCC) [1,2]. In a study of 420
subjects diagnosed with NAFLD and followed for a mean
period of 7.6 years, Adams et al. reported that 21 patients
were diagnosed with liver cirrhosis at final follow-up, indi-
cating that about 1% of NAFLD cases progressed to liver
cirrhosis yearly [3]. Progression from NASH-associated
liver cirrhosis to HCC within 5 years occurs at a higher
rate of 11.3%, although this is still lower than the 30.5%
rate of progression of hepatitis C virus (HCV)-associated
liver cirrhosis [4]. High frequencies of HCC (50%) and
hepatic insufficiency (33%) have also been reported as
causes of death from NASH-associated liver cirrhosis [5].tral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the frequency of progression of NAFLD/NASH to liver
cirrhosis or subsequent complication of HCC is low.
However, the prevalence of NAFLD in thorough medical
checkups has been estimated to be about 20% [6], showing
that the number of NAFLD patients is high compared to
those with HCV-associated chronic liver disease. There-
fore, NAFLD/NASH progresses to HCC in a relatively
large number of patients, and there are concerns that this
number may increase further in the future.
Obesity- or abnormal glucose tolerance-associated in-
sulin resistance induces hepatic steatosis (‘first hit’); sub-
sequently, NASH develops following a complex process
due to ‘second hits’ such as oxidative stress, inflamma-
tory cytokines, iron, and endotoxin [7]. Obesity and in-
sulin resistance, which are the main pathogenic factors
in NASH, have also been shown to be carcinogenic risk
factors for HCC [8,9]. However, further investigation of
the risk factors and molecular mechanisms underlying
hepatocarcinogenesis is required.
Fructose is referred to as ‘fruit sugar’ because it is
abundant in fruits and is considered to be the sweetest
among all natural sugars. Sucrose (the main component
of sugar) is hydrolyzed to glucose and fructose. Common
refreshing beverages contain a high level of fructose and
excess consumption of fructose is associated with exacer-
bation of obesity and insulin resistance [10-12], which are
risk factors for HCC. Fructose may also promote liver fi-
brosis in fatty liver disease [13]. These findings suggest
that excess fructose consumption may be associated with
development of HCC from NASH, but this association
has not been fully investigated.
We previously suggested that the pathophysiology of
fatty liver disease may be determined by its etiology,
rather than by its severity [14]. The severity of hepatic
steatosis induced by a high-fructose diet is milder than
that induced by a high-fat diet. However, liver regener-
ation after hepatectomy was significantly delayed with the
high-fructose diet compared to the high-fat diet in an
animal model [14]. In this study, we investigated whether
the appearance of glutathione S-transferase placental type
(GST-P)-positive hepatocytes, which are thought to be
precancerous lesions of HCC [15], differed according to
the etiology of fatty liver disease.
Methods
Animals and diets
Seven-week-old male Sprague–Dawley rats (Kyudo,
Kumamoto, Japan) were fed a high-fat diet (54% of the
total energy [4.96 kcal/g] comprised of fat, 8% from
fructose), a high-fructose diet (total energy: 3.97 kcal/g,
fructose: 66%, fat: 11%), or a control diet (total energy:
3.81 kcal/g, fat: 12%, fructose: 10%) (all obtained from
Nosan Corporation, Kanagawa, Japan). Diethylnitrosamine(DEN) was administered in drinking water at a concentra-
tion of 50 μg/L [16] during the dietary period. The
maximal daily food intake was limited to 30 g. After
8 weeks, the animals (8 in each group) were sacrificed
under anesthesia by intraperitoneal administration of
pentobarbital and serum and liver tissue were collected.
The liver and serum samples were frozen at −80°C until
measurement. All animal experiments were approved by
the Institutional Animal Care and Use Committee of
Kagoshima University.
Evaluation of serum markers
Blood samples were collected from each rat via aortic
punctures after a fast of 12 h. Serum levels of alanine
aminotransferase (ALT), total cholesterol, and triglycer-
ides were tested using an automatic analyzer (7180 Clin-
ical Analyzer; Hitachi High-Technologies Corporation,
Tokyo, Japan). Fasting blood glucose was measured
using a glucometer (Freestyle Freedom; Nipro Co., Ltd.,
Osaka, Japan). Serum immunoreactive insulin levels
were determined by ELISA (Morinaga Institute of Bio-
logical Science, Kanagawa, Japan).
Assessment of hepatic mRNA levels
Total RNA was extracted using Isogen (Nippon Gene,
Tokyo, Japan). The relative levels of specific mRNAs in
liver were assessed by real-time quantitative polymerase
chain reaction (PCR) using Syber Premix Ex Taq (TaKaRa
Bio Inc., Shiga, Japan). Expression levels of target genes
were calculated relative to the level of β-actin. All proce-
dures were performed according to manufacturers’ instruc-
tions. The PCR primers were obtained from TaKaRa Bio
Inc. Gene expression was analyzed using the following
pairs of primers: tumor necrosis factor (TNF)-α (forward,
TCA GTT CCA TGG CCC AGA C; reverse, GTT GTC
TTT GAG ATC CAT GCC ATT); interferon (IFN)-γ (for-
ward, AGG CCA TCA GCA ACA ACA TAA GTG;
reverse, GAC AGC TTT GTG CTG GAT CTG TG);
hemeoxygenase (HO)-1 (forward, AGG TGC ACA TCC
GTG CAG AG; reverse, TCC AGG GCC GTA TAG ATA
TGG TAC A); and β-actin (forward, GGA GAT TAC TGC
CCT GGC TCC TA; reverse, GAC TCA TCG TAC TCC
TGC TTG CTG).
Oxidative stress marker
Serum and liver tissue levels of 8-hydroxydeoxyguanosine
(8-OHdG), a marker of oxidative stress-induced DNA
damage, were measured using an 8-OHdG Check ELISA
kit (Japan Institute for the Control of Aging, Nikken SEIL
Co., Ltd., Shizuoka, Japan).
Histological examination
Tissue samples were fixed overnight in 10% phosphate-

































































Figure 1 Liver weight and liver to body weight ratio. The liver
weight (A) and the ratio of liver weight to body weight (B) were
higher in the high-fructose group compared to the control group,
and tended to be higher in the high-fat group compared to the
control group. Values are mean ± standard deviation of 8 rats.
*P <0.05.
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was performed to evaluate accumulation of fat droplets in
hepatocytes in frozen liver sections. The ratio of the oil
red O-stained area to the total area was measured on a
video display (100× magnification) in a blinded manner
using a QuickGrain digital image analyzer (Inotech,
Hiroshima, Japan).
Immunohistochemical analyses of GST-P (Medical &
Biological Laboratories Co., Ltd., Nagoya, Japan) were per-
formed using paraffin-embedded sections [17]. Samples
were incubated with goat anti-rabbit IgG (Nichirei Biosci-
ences Inc., Tokyo, Japan) to detect bound antibodies. The
number of GST-P-positive hepatocytes in liver specimens
from each rat was counted in 15 random fields at 100×
magnification [17]. The incidence refers to the percentage
of rats bearing GST-P-positive hepatocytes in each group,
while the multiplicity represents the average number of
GST-P-positive hepatocytes in positive specimens.
Statistical analysis
Data are shown as the mean ± standard deviation (SD).
Statistical comparison among groups was performed using
Kruskal-Warris or χ2 test, and group means were consid-
ered to be significantly different at P <0.05 as determined
by Games-Howell test.
Results
General appearance and serum parameters
Body weight in the high-fat group (body weight [mean ±
SD] =529 ± 64 g) was higher than that in the high-fructose
(506 ± 32 g) or control groups (489 ± 25 g) after the
8-week experimental period with oral intake of DEN, but
there was no significant difference since the maximal food
intake was limited to 30 g/day/animal in all groups. In
contrast, liver weight and liver to body weight ratio were
significantly or tended to be higher in the high-fructose or
high-fat groups compared to the control group after
8 weeks, respectively (Figure 1).
Serum levels of ALT were significantly different among
the three groups and were higher in the high-fat and high-
fructose groups compared to the control group (Table 1).
Serum total cholesterol levels were similar among the three
groups, but serum triglyceride was significantly lower in
the high-fat group compared to the high-fructose and con-
trol groups. Fasting blood glucose levels were higher in the
high-fructose group compared to the high-fat group.
Serum insulin levels were also higher in the high-fructose
group compared to the high-fat group (Table 1).
Hepatic steatosis and fibrosis
Histological evaluation by hematoxylin and eosin stain-
ing showed fat droplet deposition in hepatocytes in the
high-fructose and high-fat groups (Figure 2B,C), but no
apparent liver fibrosis in any group (Figure 2A-C). Inaddition, oil red O staining showed more marked fat
deposition in the high-fat group (Figure 2E) than in the
control or high-fructose groups (Figure 2D or F, respect-
ively), and this difference was significant (Figure 2G).Precancerous hepatocytes induced by oral administration
of DEN
Liver tissue was evaluated by GST-P staining because GST-
P-positive cells are thought to be characteristic of pre-
cancerous lesions [15]. There were more GST-P-positive
hepatocytes in the high-fructose group (Figure 3E,F) com-
pared to the high-fat group (Figure 3C,D). One slide was
randomly selected from each of the left, right, and middle
lobes and evaluated for each rat in each group (3 slides × 8
animals = 24 slides/group). The ratio of slides containing
GST-P-positive hepatocytes differed significantly among
the three groups (P = 0.03), with the highest ratio (62.5%;
15/24) in the high-fructose group followed by the high-fat
group (Table 2).
The slides from each of the left, right, and middle
lobes were also observed at 100× magnification and 15
visual fields from each slide were randomly selected (3
slides × 15 visual fields/animal × 8 rats/group = 360 visual
fields in each group). The number of GST-P-positive he-
patocytes was highest in the high-fructose group (Table 2,
P <0.001), whereas the numbers were small in the high-
fat and control groups. The mean number of GST-P-
positive hepatocytes in positive slides was 14.1 in the
high-fructose group, which was greater than those in the
high-fat and control groups (Table 2).
Table 1 Serum biochemical markers after 8 weeks of diet intake
Control High fat High fructose P value*
ALT (IU/L) 13.5 ± 5.2 26.1 ± 9.9 23.9 ± 10.0 0.01
Total cholesterol (mg/dL) 60.8 ± 7.7 57.6 ± 6.4 69.0 ± 15.7 0.37
Triglyceride (mg/dL) 104.3 ± 37.3 49.1 ± 13.2# 149.7 ± 54.6## 0.001
Fasting blood glucose (mg/dL) 133.4 ± 15.9 109.8 ± 31.3# 151.6 ± 14.2## 0.01
Insulin (ng/mL) 3.58 ± 1.89 3.23 ± 1.27 5.92 ± 1.80## 0.03
Data are shown as mean ± standard deviation. ALT, Alanine aminotransferase. *P values determined by Kruskal-Wallis test. #P <0.05 vs. control group
(Games-Howell test). ##P <0.05 vs. high-fat group (Games-Howell test).
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high-fat groups
Hepatic expression levels of TNF-α mRNA were similar
among the three groups (Figure 4A). In contrast, hepatic
levels of IFN-γ mRNA were 1.9- and 1.7-fold higher in
the high-fructose group compared to those in the high-
fat and control groups, respectively (Figure 4B). Hepatic
mRNA expression of HO-1 was lower in the high-fructose
group compared to the high-fat and control groups
(Figure 4C), but these differences did not reach statistical
significance.
Higher oxidative stress in rats with a high-fructose diet
The serum 8-OHdG level differed significantly among the
three groups (P = 0.03); this level was significantly higher






















Figure 2 Effects of a high-fructose diet with DEN intake on hepatic st
staining was observed in the liver in rats fed a high-fat diet (B) and a high-
hepatic fibrosis was not observed in any of these groups. (D-F) Oil red O s
group (E) than in the high-fructose group (F), and this difference was sign
*P <0.05.higher in the high-fat group compared to the control
group (Figure 5A). The 8-OHdG level in liver tissue
tended to be higher in the high-fructose group compared
to the control group and the high-fat group (Figure 5B).
Discussion
NAFLD/NASH and its accompanying pathophysiology,
severe obesity, and glucose intolerance are important risk
factors for HCC [8,9,18] and an increase in the number of
patients with HCC with a background of metabolic syn-
drome is of major concern. Excessive intake of fat or fruc-
tose is also a potential risk factor for hepatocarcinogenesis
[17,19]; however, the underlying mechanisms are not well
understood. Further, it is unclear whether development of
HCC and the mechanism of hepatocarcinogenesis differ






























eatosis. (A-C) Fat droplet deposition evaluated by hematoxylin-eosin
fructose diet (C), but not in those fed a control diet (A). In addition,
taining showed that fat deposition was more marked in the high-fat





















Figure 3 Effects of a high-fructose diet and DEN intake on precancerous GST-P-positive hepatocytes. (A-F) Immunohistochemical staining
of GST-P in liver sections of rats given a control diet (A,B), a high-fat diet (C,D), or a high-fructose diet (E,F) with DEN for 8 weeks (A, C and E,
magnification 100×; B, D and F, magnification 400×). The number of GST-P-positive hepatocytes seems to be greater in the high-fructose group
than in the high-fat group.
Kumamoto et al. European Journal of Medical Research 2013, 18:54 Page 5 of 8
http://www.eurjmedres.com/content/18/1/54this study, we used high-fat and high-fructose diets to
prepare abnormal lipid-induced and abnormal glucose
metabolism-induced hepatic steatosis, respectively. Rats
were exposed to DEN in drinking water throughout the
study to induce formation of GST-P-positive hepatocytes,
which are thought to be precancerous lesions [15]. The
hepatic steatosis induced by a high-fat diet was more se-
vere than that induced by a high-fructose diet, but GST-P-
positive hepatocytes were more frequent in high-fructose
group , suggesting that excess fructose consumption pro-
motes hepatocarcinogenesis to a greater degree.Table 2 Precancerous hepatocytes induced by oral administra
The number of slides containing GST-P-positive hepatocytes in 24 slides
The number of GST-P-positive hepatocytes in 360 fields
The number of GST-P-positive hepatocytes in GST-P positive slides
Data are shown as the number or mean ± standard deviation. *P values determinedThe number of patients with non-alcoholic, non-viral
chronic liver diseases such as NAFLD and NASH has
increased with the increase in patients with diseases as-
sociated with metabolic syndrome, such as obesity, dia-
betes, and dyslipidemia. The Japan Public Health Center
Study showed that the presence of diabetes increases the
risk of HCC, with hazards ratio of 2.24 in males and
1.94 in females compared to those without diabetes [20].
In a comparison of the long-term prognosis in 72 NASH
patients and 101 non-NASH patients, Rafiq et al. found
no significant difference in overall mortality, but ation of DEN with 8 weeks of diet
Control High fat High fructose P value*
6 9 15 0.03
7 12 212 <0.001
1.17 ± 0.41 1.33 ± 0.71 14.1 ± 37.9 0.03






































































Figure 4 Hepatic mRNA expression of tumor necrosis factor (TNF)-α, interferon (IFN)-γ and hemeoxygenase (HO)-1 assessed by reverse
transcription-quantitative PCR after 8 weeks of dietary intake with diethylnitrosamine in drinking water. (A) Hepatic expression TNF-α
mRNA in rats fed a high-fructose diet was similar to that in rats fed a high-fat or control diet. (B) Hepatic expression of IFN-γ mRNA tended to be
higher in rats fed a high-fructose diet compared to that in rats fed a high-fat or control diet. (C) Hepatic expression of HO-1 mRNA tended to be
lower in rats fed a high-fructose diet compared to that in rats fed a high-fat or control diet. *mRNA level normalized using that of β-actin. Values
are means ± standard deviation of 8 rats.
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http://www.eurjmedres.com/content/18/1/54significantly higher onset of liver-related diseases in the
NASH group, with NASH and the presence of type 2
diabetes emerging as independent risk factors for liver
disease-related death [21]. Thus, abnormal glucose me-
tabolism seems to be an important risk factor for liver
disease, including HCC. In our previous study, an insulin
tolerance test showed an increased high-fructose diet-
induced insulin resistance [14]; further, fasting blood




























































Figure 5 Serum and liver tissue levels of 8-
hydroxydeoxyguanosine (8-OHdG). (A) The serum 8-OHdG level
differed significantly among the three groups (P = 0.03), and this
level tended to be or was significantly higher in the high-fructose
group than in the high-fat or control groups, respectively. Values are
means ± standard deviation of 8 rats. *P <0.05. (B) The 8-OHdG level
in liver tissue tended to be higher in the high-fructose group (n = 8)
compared to that in the high-fat (n = 7) or control groups (n = 8).high-fructose group compared to the high-fat group in
the current study. These results suggest that hepatocar-
cinogenesis due to a high-fructose diet involves insulin
resistance and/or abnormal glucose metabolism. The asso-
ciation of hepatocarcinogenesis with insulin resistance or
abnormal glucose metabolism induced by conditions other
than a high-fructose diet requires further investigation.
Previous epidemiological studies have been unable to
clarify whether lipid abnormalities are involved in the pro-
gression of hepatocarcinogenesis in patients with NASH.
In a basic study, Wang et al. compared the number of
GST-P-positive hepatocytes in the liver in SD rats given
intraperitoneal administration of DEN at 30 mg/kg body
weight and then fed with a high-fat or control diet for
6 weeks, in which 71% and 35% of the total calories were
derived from fat, respectively [17]. GST-P-positive hepato-
cytes appeared in both groups, but these cells only formed
foci in the high-fat group. Since GST-P-positive hepato-
cytes are assumed to be precancerous lesions, a high-fat
diet may promote development of HCC compared to a
control diet. Wang et al. also showed that the increase in
foci of GST-P-positive hepatocytes in rats fed a high-fat
diet caused an increase in intrahepatic oxidative stress
[17]. In our study, more GST-P-positive hepatocytes were
present in rats fed a high-fat diet than in controls, but the
frequency was higher in those fed a high-fructose diet, in
accordance with oxidative stress-induced DNA damage.
In contrast, there was a tendency for low expression levels
of HO-1 mRNA in the high-fructose group compared to
the high-fat group. HO-1 is an oxidative stress marker,
but upregulation of HO-1 reduces oxidative stress in or-
gans such as the kidneys in diabetic spontaneously
hypertensive rats [22]. Induction of HO-1 also reduces
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trauma hemorrhage [24], while inhibition of HO-1 may
be associated with acetaminophen-induced liver injury
[25]. Furthermore, IFN-γ, which was higher in the high-
fructose group compared to the high-fat and control
groups in the present study, inhibits both basal and
lipopolysaccharide-induced HO-1 expression in macro-
phages [26]. Therefore, the results of the present study
suggest that the possible ability of HO-1 to reduce oxida-
tive stress induced by DEN administration was inhibited
by a high-fructose diet. Thus, although high fat and high
fructose intake may both induce hepatocarcinogenesis, a
high-fructose diet is more likely to be associated with
hepatocarcinogenesis through excess oxidative stress.
Three steps of progression from NAFLD to hepatocar-
cinogenesis have been proposed: initiation, promotion,
and progression. Hepatic mRNA expression of IFN-γ
tended to be higher in the high-fructose group com-
pared to the other two groups in this study. Intrahepatic
IFN-γ mRNA expression has been found to be induced
2 months before the appearance of HCC and IFN-γ may
be important in the initiation step of hepatocarcinogen-
esis in mice exposed to DEN in drinking water [16].
Therefore, high fructose intake may also be associated
with this step, rather than promotion and progression.
Lipid hyperoxidation and p53 mutation are also associ-
ated with initiation [27], but it is unclear whether excess
fructose intake is associated with hepatocarcinogenesis
through lipid hyperoxidation and gene mutation in our
study. Thus, the associations of high fructose intake with
all three steps remain to be investigated. In addition, our
present and previous [14] studies indicated that hepato-
carcinogenesis and delayed liver regeneration were more
severe in rats fed a high-fructose diet than in those fed a
high-fat diet, although hepatic steatosis was more severe
in rats fed a high-fat diet. In contrast, promotion of
hepatocyte proliferation through enhanced expression of
MAPK-related genes has been associated with hepato-
carcinogenesis [17]. Thus, the mechanism or steps of
hepatocarcinogenesis may differ between high-fructose
and high-fat diets.
Our study has several limitations. First, the frequency
of formation of GST-P-positive hepatocyte foci was lower
in our model than in that of Wang et al. [17]. This may be
due to the difference in route of DEN administration and
restriction of food intake. Second, serum triglyceride and
fasting blood glucose levels were lower in the high-fat
group than those in the control group, in conflict with
previous findings [14]. However, Huang et al. also reported
that the high-fat diet group had a lower triglyceride con-
centration than the control group [28]. The total energy
comprised of fat and restriction of food intake may influ-
ence these results. Third, we used β-actin as a housekeep-
ing gene, but little is known about changes in expressionof this gene after DEN or fructose administration. Ex-
pression of several genes, including β-actin, has been
suggested to increase after DEN administration [29].
However, this change should not affect the significance
of our results because all groups in the study received
DEN. In addition, GAPDH mRNA initially decreases by
almost half and then gradually increases up to 3-fold by
48 h after DEN administration [29]. GAPDH expression
may also have differed among the three groups in the
present study because GAPDH has roles in activities
such as glycolysis and DNA repair that may have dif-
fered among the groups [30]. Therefore, β-actin was
chosen as a more suitable housekeeping gene compared
to GAPDH. Fourth, a high-fructose diet tended to in-
crease IFN-γ mRNA and decrease HO-1 mRNA, but the
expression levels were highly variable. IFN-γ protein in
liver tissue was also higher in the high-fructose group
compared to the high-fat group (data not shown), but the
difference was not significant. Further examination of
these changes using methods such as immunohistochem-
istry is required. Finally, it is unclear whether the observed
differences in our study are related to an increased inci-
dence of HCC or an increased tumor burden in rats. A
longer-term analysis is required to address this issue.
Conclusions
In conclusion, dietary fructose, rather than dietary fat, en-
hances hepatocarcinogenesis induced by administration of
DEN in rats. This effect seems to be associated with oxi-
dative stress and abnormal glucose metabolism including
insulin resistance, rather than the severity of hepatic stea-
tosis. These results suggest that excessive intake of fruc-
tose is a potential risk factor for liver cancer in patients
with NASH.
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